Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06326502
Status:
RECRUITING
Last Update Posted:
2024-03-27
First Post:
2024-03-17
Brief Title:
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug ETN101 in Advanced Hepatocellular Carcinoma
Sponsor:
Etnova Therapeutics Corp
Organization:
Etnova Therapeutics Corp
Organization Data
Organization:
Etnova Therapeutics Corp
Class:
INDUSTRY
Study ID:
22ETN101-2IND001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Etnova Therapeutics Corp
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None